In October, Pakistan got about 500,000 extra doses of the COVID-19 vaccine from AstraZeneca, thanks to donations from Sweden, Norway, and Switzerland. This raises the total number of doses delivered to Pakistan through the COVAX global effort and donations from other countries to over four million, with more on the way in the coming months.
“Our COVAX partners have played a vital role in ensuring vaccination doses reach those nations in need,” said Sameh Elfangary, AstraZeneca’s Country President for the Gulf Cooperation Council and Pakistan. The availability of vaccinations is critical to limiting the pandemic’s impact in Pakistan, and the country is showing signs of recovery, with fewer COVID-19 cases reported. We are dedicated to ensuring that everyone has access to vaccines, and we will continue to collaborate with the Pakistani government to combat the epidemic and defend public health.”
More than 1.7 billion doses of AstraZeneca’s vaccine have been distributed to over 170 countries so far, with more than two-thirds of the doses going to low- and lower-middle-income nations. In June 2020, AstraZeneca became the first multinational pharmaceutical firm to join COVAX, and more than 157 million doses of their vaccine have been supplied to 130 countries through COVAX to far.
COVAX is a global initiative co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi (the Vaccines Alliance) and the World Health Organization (WHO), which works with governments and manufacturers to accelerate the development, production and equitable access to COVID-19 vaccines around the world.
From the 585 million people who had received at least one dose of COVID-19 Vaccine AstraZeneca as of September 2021, the vaccine has prevented over 105,000 deaths and over 620,000 hospitalizations worldwide.1